Folate-dependent hydrolysis of acetyl-coenzyme A by recombinant human and rodent arylamine N-acetyltransferases

de Leon, 2000, Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1, Mol. Pharmacol., 58, 288, 10.1124/mol.58.2.288

Fretland, 2001, Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1, Pharmacogenetics, 11, 511, 10.1097/00008571-200108000-00006

Evans, 1960, Genetic control of isoniazid metabolism in man, Br. Med. J., 2, 485, 10.1136/bmj.2.5197.485

Parker, 1969, Human variability in the metabolism of sulfamethazine, Hum. Hered., 19, 402, 10.1159/000152245

Blum, 1990, Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression, DNA Cell Biol., 9, 193, 10.1089/dna.1990.9.193

Boukouvala, 2005, Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts, Basic Clin. Pharmacol. Toxicol., 96, 343, 10.1111/j.1742-7843.2005.pto_02.x

Pacifici, 1986, Acetyltransferase in humans: development and tissue distribution, Pharmacology, 32, 283, 10.1159/000138181

Windmill, 1997, The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies, Mutat. Res., 376, 153, 10.1016/S0027-5107(97)00038-9

Hein, 2008, Changes in consensus arylamine N-acetyltransferase gene nomenclature, Pharmacogenet. Genomics, 18, 367, 10.1097/FPC.0b013e3282f60db0

Goodfellow, 2000, Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2, Biochem. J., 348, 159, 10.1042/bj3480159

Mushtaq, 2002, The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity, J. Biol. Chem., 277, 12175, 10.1074/jbc.M104365200

Walraven, 2006, Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2, J. Pharmacol. Exp. Ther., 319, 369, 10.1124/jpet.106.108399

Wakefield, 2008, Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system, Biomarkers, 13, 106, 10.1080/13547500701673529

Witham, 2013, 5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion, PLoS One, 8, e77923, 10.1371/journal.pone.0077923

Minchin, 1995, Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells, Biochem. J., 307, 1, 10.1042/bj3070001

Laurieri, 2014, From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2, PLoS One, 9, e96370, 10.1371/journal.pone.0096370

Hein, 1993, Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases, Carcinogenesis, 14, 1633, 10.1093/carcin/14.8.1633

Doll, 1995, Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats, Pharmacogenetics, 5, 247, 10.1097/00008571-199508000-00009

Ferguson, 1994, Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli, Pharmacogenetics, 4, 82, 10.1097/00008571-199404000-00005

Ferguson, 1996, Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster, Pharmacogenetics, 6, 55, 10.1097/00008571-199602000-00004

Hein, 2006, Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster, Mol. Carcinog., 45, 230, 10.1002/mc.20164

Deghan Manshadi, 2014, Folic acid supplementation promotes mammary tumor progression in a rat model, PLoS One, 9, e84635, 10.1371/journal.pone.0084635

Colapinto, 2014, The direction of the difference between Canadian and American erythrocyte folate concentrations is dependent on the assay method employed: a comparison of the Canadian health measures survey and the national health and nutrition examination survey, Br. J. Nutr., 112, 1873, 10.1017/S0007114514002906

Llanos, 2015, Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues, Carcinogenesis, 36, 60, 10.1093/carcin/bgu219

Hein, 2008, Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat, Drug Metab. Dispos.:, 36, 2452, 10.1124/dmd.108.023960

Wakefield, 2008, Arylamine N-acetyltransferase I expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors, Genes Chromosomes Cancer, 47, 118, 10.1002/gcc.20512

Tiang, 2011, RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition, PLoS One, 6, e17031, 10.1371/journal.pone.0017031

Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093

Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. USA, 98, 10869, 10.1073/pnas.191367098

van’t Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a

Weigelt, 2003, Gene expression profiles of primary breast tumors maintained in distant metastases, Proc. Natl. Acad. Sci. USA, 100, 15901, 10.1073/pnas.2634067100

Bertucci, 2004, Identification and validation of an ERBB2 gene expression signature in breast cancers, Oncogene, 23, 2564, 10.1038/sj.onc.1207361